ID

DB00219|APRD00189||

名称

Oxyphenonium

描述

A quaternary ammonium anticholinergic agent with peripheral side effects similar to those of atropine. It is used as an adjunct in the treatment of gastric and duodenal ulcer, and to relieve visceral spasms. The drug has also been used in the form of eye drops for mydriatic effect. [PubChem]

cas号

14214-84-7

唯一标识码

D2G5508Y7I

状态

solid

组

approved,

指示

For the treatment of visceral spasms

药效学

Oxyphenonium is an anticholinergic drug, a medication that reduces the effect of acetylcholine, a chemical released from nerves that stimulates muscles, by blocking the receptors for acetylcholine on smooth muscle (a type of muscle). It also has a direct relaxing effect on smooth muscle. Oxyphenonium is used to treat or prevent spasm in the muscles of the gastrointestinal tract in the irritable bowel syndrome. In addition, Oxyphenonium inhibits gastrointestinal propulsive motility and decreases gastric acid secretion and controls excessive pharyngeal, tracheal and bronchial secretions.

作用机制

Action is achieved via a dual mechanism: (1) a specific anticholinergic effect (antimuscarinic) at the acetylcholine-receptor sites and (2) a direct effect upon smooth muscle (musculotropic).

毒性

代谢

吸收

半衰期

分类

description:This compound belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene.
direct-parent:Benzene and substituted derivatives
kingdom:Organic compounds
superclass:Benzenoids
class:Benzene and substituted derivatives
subclass:
alternative-parent:Amines
alternative-parent:Aromatic alcohols
alternative-parent:Carbonyl compounds
alternative-parent:Carboxylic acid esters
alternative-parent:Hydrocarbon derivatives
alternative-parent:Monocarboxylic acids and derivatives
alternative-parent:Organic cations
alternative-parent:Organic oxides
alternative-parent:Organic salts
alternative-parent:Organopnictogen compounds
alternative-parent:Tertiary alcohols
alternative-parent:Tetraalkylammonium salts
substituent:Alcohol
substituent:Amine
substituent:Aromatic alcohol
substituent:Aromatic homomonocyclic compound
substituent:Carbonyl group
substituent:Carboxylic acid derivative
substituent:Carboxylic acid ester
substituent:Hydrocarbon derivative
substituent:Monocarboxylic acid or derivatives
substituent:Monocyclic benzene moiety
substituent:Organic cation
substituent:Organic nitrogen compound
substituent:Organic oxide
substituent:Organic oxygen compound
substituent:Organic salt
substituent:Organonitrogen compound
substituent:Organooxygen compound
substituent:Organopnictogen compound
substituent:Quaternary ammonium salt
substituent:Tertiary alcohol
substituent:Tetraalkylammonium salt

消除途径

种类

Agents producing tachycardia

Alimentary Tract and Metabolism

Amines
D000588
Ammonium Compounds
D064751
Anticholinergic Agents
D018680
Autonomic Agents
D001337
Cholinergic Agents
D018678
Drugs for Functional Gastrointestinal Disorders

Muscarinic Antagonists
D018727
Mydriatics
D009184
Neurotransmitter Agents
D018377
Nitrogen Compounds
D017672
Onium Compounds
D009861
Parasympatholytics
D010276
Peripheral Nervous System Agents
D018373
Quaternary Ammonium Compounds
D000644
Synthetic Anticholinergics, Quaternary Ammonium Compounds

盐类

DBSALT000207Oxyphenonium bromideS9421HWB3Z50-10-2UKLQXHUGTKWPSR-UHFFFAOYSA-M428.404427.172206606

蛋白质结合

93% bound to albumin

清除

同义词

language:english; code:; name;Oxyphenonium cation
language:english; code:; name;Oxyphenonium ion

国际品牌

A-SpasmAntispasminAntrenexAntrenylAtrenexSpasmophen

配送量

产品

混合物

包装者

生产者

generic:否; url:; name;Novartis pharmaceuticals corp

价格

受影响的生物体

Humans and other mammals

剂量

atc代码

Synthetic anticholinergics, quaternary ammonium compounds
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
ALIMENTARY TRACT AND METABOLISM
Synthetic anticholinergics, quaternary ammonium compounds
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
ALIMENTARY TRACT AND METABOLISM

fda标签

化学品安全技术说明书

专利

食物相互作用

药物相互作用

DB08897
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Aclidinium.
DB06148
Mianserin may increase the anticholinergic activities of Oxyphenonium.
DB08893
The risk or severity of urinary retention can be increased when Oxyphenonium is combined with Mirabegron.
DB00761
The risk or severity of gastrointestinal ulceration can be increased when Oxyphenonium is combined with Potassium chloride.
DB01278
The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Oxyphenonium.
DB09527
The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Oxyphenonium.
DB01409
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Tiotropium.
DB00273
The risk or severity of hyperthermia and oligohydrosis can be increased when Oxyphenonium is combined with Topiramate.
DB09076
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Umeclidinium.
DB00986
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Glycopyrronium.
DB00083
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Botulinum toxin type A.
DB00040
Oxyphenonium may increase the gastrointestinal motility reducing activities of Glucagon.
DB00391
Oxyphenonium may increase the anticholinergic activities of Sulpiride.
DB00042
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Botulinum Toxin Type B.
DB09272
The risk or severity of constipation can be increased when Oxyphenonium is combined with Eluxadoline.
DB09290
The risk or severity of constipation can be increased when Oxyphenonium is combined with Ramosetron.
DB00704
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Naltrexone.
DB01459
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Bezitramide.
DB00193
The risk or severity of adverse effects can be increased when Tramadol is combined with Oxyphenonium.
DB00295
The risk or severity of adverse effects can be increased when Morphine is combined with Oxyphenonium.
DB00318
The risk or severity of adverse effects can be increased when Codeine is combined with Oxyphenonium.
DB00327
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Oxyphenonium.
DB00333
The risk or severity of adverse effects can be increased when Methadone is combined with Oxyphenonium.
DB00454
The risk or severity of adverse effects can be increased when Meperidine is combined with Oxyphenonium.
DB00497
The risk or severity of adverse effects can be increased when Oxycodone is combined with Oxyphenonium.
DB00611
The risk or severity of adverse effects can be increased when Butorphanol is combined with Oxyphenonium.
DB00647
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Oxyphenonium.
DB00652
The risk or severity of adverse effects can be increased when Pentazocine is combined with Oxyphenonium.
DB00708
The risk or severity of adverse effects can be increased when Sufentanil is combined with Oxyphenonium.
DB00802
The risk or severity of adverse effects can be increased when Alfentanil is combined with Oxyphenonium.
DB00813
The risk or severity of adverse effects can be increased when Fentanyl is combined with Oxyphenonium.
DB00844
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxyphenonium.
DB00854
The risk or severity of adverse effects can be increased when Levorphanol is combined with Oxyphenonium.
DB00899
The risk or severity of adverse effects can be increased when Remifentanil is combined with Oxyphenonium.
DB00921
The risk or severity of adverse effects can be increased when Buprenorphine is combined with Oxyphenonium.
DB00956
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Oxyphenonium.
DB01081
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Oxyphenonium.
DB01192
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Oxyphenonium.
DB01209
The risk or severity of adverse effects can be increased when Dezocine is combined with Oxyphenonium.
DB01227
The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Oxyphenonium.
DB01433
The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Oxyphenonium.
DB01450
The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Oxyphenonium.
DB01452
The risk or severity of adverse effects can be increased when Diamorphine is combined with Oxyphenonium.
DB01466
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Oxyphenonium.
DB01497
The risk or severity of adverse effects can be increased when Etorphine is combined with Oxyphenonium.
DB01529
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Oxyphenonium.
DB01531
The risk or severity of adverse effects can be increased when Desomorphine is combined with Oxyphenonium.
DB01535
The risk or severity of adverse effects can be increased when Carfentanil is combined with Oxyphenonium.
DB01551
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Oxyphenonium.
DB01555
The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Oxyphenonium.
DB01565
The risk or severity of adverse effects can be increased when Dihydromorphine is combined with Oxyphenonium.
DB06204
The risk or severity of adverse effects can be increased when Tapentadol is combined with Oxyphenonium.
DB06738
The risk or severity of adverse effects can be increased when Ketobemidone is combined with Oxyphenonium.
DB08861
The risk or severity of adverse effects can be increased when DPDPE is combined with Oxyphenonium.
DB09174
The risk or severity of adverse effects can be increased when Lofentanil is combined with Oxyphenonium.
DB11130
The risk or severity of adverse effects can be increased when Opium is combined with Oxyphenonium.
DB11609
The risk or severity of adverse effects can be increased when Normethadone is combined with Oxyphenonium.
DB12492
The risk or severity of adverse effects can be increased when Piritramide is combined with Oxyphenonium.
DB13160
The risk or severity of adverse effects can be increased when Alphaprodine is combined with Oxyphenonium.
DB13454
The risk or severity of adverse effects can be increased when Nicomorphine is combined with Oxyphenonium.
DB13478
The risk or severity of adverse effects can be increased when Meptazinol is combined with Oxyphenonium.
DB13605
The risk or severity of adverse effects can be increased when Phenoperidine is combined with Oxyphenonium.
DB13606
The risk or severity of adverse effects can be increased when Phenazocine is combined with Oxyphenonium.
DB13787
The risk or severity of adverse effects can be increased when Tilidine is combined with Oxyphenonium.
DB15360
The risk or severity of adverse effects can be increased when Carfentanil, C-11 is combined with Oxyphenonium.
DB15465
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Benzhydrocodone.
DB00209
The risk or severity of adverse effects can be increased when Trospium is combined with Oxyphenonium.
DB00245
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Benzatropine.
DB00280
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Disopyramide.
DB00340
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Metixene.
DB00342
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Terfenadine.
DB00354
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Buclizine.
DB00376
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Trihexyphenidyl.
DB00383
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Oxyphencyclimine.
DB00387
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Procyclidine.
DB00424
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hyoscyamine.
DB00462
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Methscopolamine bromide.
DB00496
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Darifenacin.
DB00505
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Tridihexethyl.
DB00517
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Anisotropine methylbromide.
DB00572
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Atropine.
DB00622
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Nicardipine.
DB00657
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Mecamylamine.
DB00670
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Pirenzepine.
DB00725
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Homatropine methylbromide.
DB00767
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Benzquinamide.
DB00782
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Propantheline.
DB00804
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Dicyclomine.
DB00809
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Tropicamide.
DB00907
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Cocaine.
DB00908
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Quinidine.
DB00915
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Amantadine.
DB00940
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Methantheline.
DB00942
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Cycrimine.
DB00979
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Cyclopentolate.
DB01036
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Tolterodine.
DB01062
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Oxybutynin.
DB01090
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Pentolinium.
DB01116
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Trimethaphan.
DB01148
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Flavoxate.
DB01161
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Chloroprocaine.
DB01231
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Diphenidol.
DB01288
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Fenoterol.
DB01496
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione.
DB01591
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Solifenacin.
DB01625
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Isopropamide.
DB04843
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Mepenzolate.
DB06702
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Fesoterodine.
DB06787
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hexocyclium.
DB08801
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Dimetindene.
DB08838
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Agmatine.
DB08997
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Dexetimide.
DB09007
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Chlorphenoxamine.
DB09089
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Trimebutine.
DB09262
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Imidafenacin.
DB09300
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Butylscopolamine.
DB11181
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Homatropine.
DB11235
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Thonzylamine.
DB11315
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Methscopolamine.
DB11855
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Revefenacin.
DB12086
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Oxitropium.
DB12278
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Propiverine.
DB12526
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Batefenterol.
DB12554
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Mebeverine.
DB13252
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Tropatepine.
DB13254
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Prifinium.
DB13351
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Piperidolate.
DB13369
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Benzilone.
DB13380
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Difemerine.
DB13413
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Phenglutarimide.
DB13448
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Mazaticol.
DB13468
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Etybenzatropine.
DB13500
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Otilonium.
DB13507
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Poldine.
DB13542
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Bevonium.
DB13581
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Rociverine.
DB13619
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Bornaprine.
DB13636
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Etanautine.
DB13666
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Tiemonium iodide.
DB13678
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Dihexyverine.
DB13695
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Penthienate.
DB13720
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Diphemanil.
DB13738
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Camylofin.
DB13759
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Fenpiverinium.
DB13769
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Emetonium iodide.
DB13844
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Pipenzolate.
DB13850
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Timepidium.
DB09271
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Cimetropium.
DB00232
The serum concentration of Methyclothiazide can be increased when it is combined with Oxyphenonium.
DB00310
The serum concentration of Chlorthalidone can be increased when it is combined with Oxyphenonium.
DB00436
The serum concentration of Bendroflumethiazide can be increased when it is combined with Oxyphenonium.
DB00524
The serum concentration of Metolazone can be increased when it is combined with Oxyphenonium.
DB00562
The serum concentration of Benzthiazide can be increased when it is combined with Oxyphenonium.
DB00774
The serum concentration of Hydroflumethiazide can be increased when it is combined with Oxyphenonium.
DB00808
The serum concentration of Indapamide can be increased when it is combined with Oxyphenonium.
DB00880
The serum concentration of Chlorothiazide can be increased when it is combined with Oxyphenonium.
DB00999
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Oxyphenonium.
DB01021
The serum concentration of Trichlormethiazide can be increased when it is combined with Oxyphenonium.
DB01324
The serum concentration of Polythiazide can be increased when it is combined with Oxyphenonium.
DB01325
The serum concentration of Quinethazone can be increased when it is combined with Oxyphenonium.
DB13532
The serum concentration of Cyclopenthiazide can be increased when it is combined with Oxyphenonium.
DB13989
The serum concentration of Epitizide can be increased when it is combined with Oxyphenonium.
DB00332
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Ipratropium.
DB00470
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Dronabinol.
DB00486
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Nabilone.
DB05077
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with SLV319.
DB06155
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Rimonabant.
DB06624
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Taranabant.
DB09061
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Cannabidiol.
DB11903
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with GW842166.
DB12193
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Ajulemic acid.
DB12649
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Ibipinabant.
DB13070
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Surinabant.
DB13950
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with WIN 55212-2.
DB14011
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Nabiximols.
DB14043
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Palmidrol.
DB14737
The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Cannabinol.
DB00082
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Pegvisomant.
DB00358
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Mefloquine.
DB00382
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Tacrine.
DB00392
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Profenamine.
DB00515
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Cisplatin.
DB00527
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Cinchocaine.
DB00545
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Pyridostigmine.
DB00585
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Nizatidine.
DB00674
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Galantamine.
DB00677
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Isoflurophate.
DB00711
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Diethylcarbamazine.
DB00871
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Terbutaline.
DB00888
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Mechlorethamine.
DB00944
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Demecarium.
DB00981
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Physostigmine.
DB00989
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Rivastigmine.
DB01010
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Edrophonium.
DB01035
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Procainamide.
DB01043
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Memantine.
DB01122
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Ambenonium.
DB01381
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Ginkgo biloba.
DB01400
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Neostigmine.
DB01408
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Bambuterol.
DB02365
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with 1,10-Phenanthroline.
DB04572
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Thiotepa.
DB04864
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Huperzine A.
DB04892
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Phenserine.
DB05386
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Regramostim.
DB06692
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Aprotinin.
DB06756
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Glycine betaine.
DB06774
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Capsaicin.
DB11390
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Coumaphos.
DB11397
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Dichlorvos.
DB11412
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Fenthion.
DB11473
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Metrifonate.
DB12482
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Acotiamide.
DB13058
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Methanesulfonyl Fluoride.
DB13495
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Paraoxon.
DB13503
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Tyrothricin.
DB13668
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Ipidacrine.
DB13694
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Distigmine.
DB14031
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Tretamine.
DB15317
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Posiphen.
DB02845
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Methylphosphinic Acid.
DB00581
The therapeutic efficacy of Lactulose can be decreased when used in combination with Oxyphenonium.
DB01046
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Oxyphenonium.
DB01079
The therapeutic efficacy of Tegaserod can be decreased when used in combination with Oxyphenonium.
DB01377
The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oxyphenonium.
DB01378
The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Oxyphenonium.
DB01593
The therapeutic efficacy of Zinc can be decreased when used in combination with Oxyphenonium.
DB01638
The therapeutic efficacy of Sorbitol can be decreased when used in combination with Oxyphenonium.
DB04816
The therapeutic efficacy of Dantron can be decreased when used in combination with Oxyphenonium.
DB04823
The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Oxyphenonium.
DB04824
The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Oxyphenonium.
DB06480
The therapeutic efficacy of Prucalopride can be decreased when used in combination with Oxyphenonium.
DB07715
The therapeutic efficacy of Emodin can be decreased when used in combination with Oxyphenonium.
DB08890
The therapeutic efficacy of Linaclotide can be decreased when used in combination with Oxyphenonium.
DB09020
The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Oxyphenonium.
DB09104
The therapeutic efficacy of Magnesium hydroxide can be decreased when used in combination with Oxyphenonium.
DB09219
The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Oxyphenonium.
DB09268
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Oxyphenonium.
DB09281
The therapeutic efficacy of Magnesium trisilicate can be decreased when used in combination with Oxyphenonium.
DB09287
The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Oxyphenonium.
DB09311
The therapeutic efficacy of Polycarbophil can be decreased when used in combination with Oxyphenonium.
DB09413
The therapeutic efficacy of Monopotassium phosphate can be decreased when used in combination with Oxyphenonium.
DB09414
The therapeutic efficacy of Dipotassium phosphate can be decreased when used in combination with Oxyphenonium.
DB09449
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Oxyphenonium.
DB09462
The therapeutic efficacy of Glycerin can be decreased when used in combination with Oxyphenonium.
DB09472
The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Oxyphenonium.
DB09481
The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Oxyphenonium.
DB09484
The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Oxyphenonium.
DB11057
The therapeutic efficacy of Mineral oil can be decreased when used in combination with Oxyphenonium.
DB11059
The therapeutic efficacy of Carboxymethylcellulose can be decreased when used in combination with Oxyphenonium.
DB11089
The therapeutic efficacy of Docusate can be decreased when used in combination with Oxyphenonium.
DB11097
The therapeutic efficacy of Plantago seed can be decreased when used in combination with Oxyphenonium.
DB11110
The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Oxyphenonium.
DB11113
The therapeutic efficacy of Castor oil can be decreased when used in combination with Oxyphenonium.
DB11189
The therapeutic efficacy of Magnesium glycinate can be decreased when used in combination with Oxyphenonium.
DB11228
The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Oxyphenonium.
DB11365
The therapeutic efficacy of Sennosides can be decreased when used in combination with Oxyphenonium.
DB12942
The therapeutic efficacy of Lactitol can be decreased when used in combination with Oxyphenonium.
DB13170
The therapeutic efficacy of Plecanatide can be decreased when used in combination with Oxyphenonium.
DB13486
The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Oxyphenonium.
DB13526
The therapeutic efficacy of Pentaerithrityl can be decreased when used in combination with Oxyphenonium.
DB13707
The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Oxyphenonium.
DB14232
The therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Oxyphenonium.
DB14482
The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Oxyphenonium.
DB14499
The therapeutic efficacy of Potassium sulfate can be decreased when used in combination with Oxyphenonium.
DB14502
The therapeutic efficacy of Sodium phosphate, dibasic can be decreased when used in combination with Oxyphenonium.
DB14503
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Oxyphenonium.
DB14504
The therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Oxyphenonium.
DB14513
The therapeutic efficacy of Magnesium can be decreased when used in combination with Oxyphenonium.
DB14585
The therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Oxyphenonium.
DB14627
The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Oxyphenonium.
DB14684
The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Oxyphenonium.
DB14963
The therapeutic efficacy of Konjac mannan can be decreased when used in combination with Oxyphenonium.
DB15477
The therapeutic efficacy of Alloin can be decreased when used in combination with Oxyphenonium.
DB15478
The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Oxyphenonium.
DB11622
The therapeutic efficacy of Dehydrocholic acid can be decreased when used in combination with Oxyphenonium.
DB14516
The therapeutic efficacy of Sodium cation can be decreased when used in combination with Oxyphenonium.
DB14546
The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Oxyphenonium.
DB00477
Chlorpromazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00483
Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00508
Triflupromazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00721
Procaine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00805
Minaprine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00941
Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01199
Tubocurarine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01221
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01245
Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01337
Pancuronium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01338
Pipecuronium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00150
Tryptophan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00176
Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00181
Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00182
Amphetamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00186
Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00189
Ethchlorvynol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00202
Succinylcholine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00206
Reserpine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00215
Citalopram may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00216
Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00228
Enflurane may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00230
Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00231
Temazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00234
Reboxetine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00237
Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00241
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00246
Ziprasidone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00247
Methysergide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00248
Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00252
Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00268
Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00283
Clemastine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00285
Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00289
Atomoxetine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00292
Etomidate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00306
Talbutal may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00312
Pentobarbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00313
Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00315
Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00320
Dihydroergotamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00321
Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00323
Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00334
Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00341
Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00344
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00347
Trimethadione may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00349
Clobazam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00356
Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00363
Clozapine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00366
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00370
Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00371
Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00372
Thiethylperazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00377
Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00395
Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00402
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00404
Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00405
Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00408
Loxapine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00409
Remoxipride may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00416
Metocurine iodide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00418
Secobarbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00420
Promazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00423
Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00425
Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00427
Triprolidine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00433
Prochlorperazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00434
Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00450
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00458
Imipramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00463
Metharbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00468
Quinine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00472
Fluoxetine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00474
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00475
Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00476
Duloxetine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00494
Entacapone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00502
Haloperidol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00514
Dextromethorphan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00532
Mephenytoin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00540
Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00543
Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00546
Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00555
Lamotrigine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00557
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00564
Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00565
Cisatracurium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00574
Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00575
Clonidine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00579
Mazindol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00588
Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00589
Lisuride may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00593
Ethosuximide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00599
Thiopental may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00601
Linezolid may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00604
Cisapride may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00614
Furazolidone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00617
Paramethadione may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00623
Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00625
Efavirenz may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00628
Clorazepic acid may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00633
Dexmedetomidine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00645
Dyclonine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00656
Trazodone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00660
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00662
Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00669
Sumatriptan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00679
Thioridazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00680
Moricizine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00683
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00690
Flurazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00696
Ergotamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00697
Tizanidine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00714
Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00715
Paroxetine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00726
Trimipramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00728
Rocuronium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00732
Atracurium besylate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00734
Risperidone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00737
Meclizine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00740
Riluzole may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00747
Scopolamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00748
Carbinoxamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00752
Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00753
Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00754
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00757
Dolasetron may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00771
Clidinium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00776
Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00777
Propiomazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00780
Phenelzine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00794
Primidone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00801
Halazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00818
Propofol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00819
Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00829
Diazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00831
Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00832
Phensuximide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00835
Brompheniramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00837
Progabide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00842
Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00849
Methylphenobarbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00850
Perphenazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00865
Benzphetamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00866
Alprenolol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00875
Flupentixol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00889
Granisetron may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00897
Triazolam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00898
Ethanol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00904
Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00906
Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00909
Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00918
Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00924
Cyclobenzaprine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00933
Mesoridazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00934
Maprotiline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00937
Diethylpropion may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00949
Felbamate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00952
Naratriptan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00953
Rizatriptan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00960
Pindolol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00962
Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00969
Alosetron may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00972
Azelastine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00980
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00985
Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00996
Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00998
Frovatriptan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01018
Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01028
Methoxyflurane may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01037
Selegiline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01041
Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01049
Ergoloid mesylate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01063
Acetophenazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01065
Melatonin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01068
Clonazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01069
Promethazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01075
Diphenhydramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01080
Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01100
Pimozide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01104
Sertraline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01105
Sibutramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01106
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01107
Methyprylon may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01114
Chlorpheniramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01121
Phenacemide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01135
Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01142
Doxepin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01149
Nefazodone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01151
Desipramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01154
Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01156
Bupropion may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01159
Halothane may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01168
Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01171
Moclobemide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01173
Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01174
Phenobarbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01175
Escitalopram may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01176
Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01178
Chlormezanone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01186
Pergolide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01189
Desflurane may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01198
Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01200
Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01202
Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01215
Estazolam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01219
Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01224
Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01226
Mivacurium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01236
Sevoflurane may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01238
Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01239
Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01242
Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01246
Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01247
Isocarboxazid may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01253
Ergometrine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01267
Paliperidone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01320
Fosphenytoin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01323
St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01336
Metocurine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01339
Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01351
Amobarbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01352
Aprobarbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01353
Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01354
Heptabarbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01355
Hexobarbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01356
Lithium cation may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01359
Penbutolol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01367
Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01392
Yohimbine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01403
Methotrimeprazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01437
Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01440
gamma-Hydroxybutyric acid may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01442
MMDA may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01445
Bufotenine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01454
Midomafetamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01463
Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01472
4-Methoxyamphetamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01483
Barbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01484
4-Bromo-2,5-dimethoxyamphetamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01488
Dimethyltryptamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01489
Camazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01495
Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01501
Difenoxin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01509
Tenamfetamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01511
Delorazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01534
Chlorhexadol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01544
Flunitrazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01545
Ethyl loflazepate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01547
Drotebanol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01553
Cloxazolam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01558
Bromazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01559
Clotiazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01560
Cathinone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01563
Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01567
Fludiazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01577
Metamfetamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01580
Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01587
Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01588
Prazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01589
Quazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01594
Cinolazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01595
Nitrazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01608
Periciazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01614
Acepromazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01615
Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01616
Alverine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01618
Molindone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01621
Pipotiazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01622
Thioproperazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01623
Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01624
Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01626
Pargyline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB01954
Rolipram may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB02207
7-Nitroindazole may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB02234
S-Ethylisothiourea may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB02852
Domoic Acid may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB02959
Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB03575
Phencyclidine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04017
Clorgiline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04165
Valpromide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04325
Phenethylamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04599
Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04818
Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04819
Methapyrilene may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04820
Nialamide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04821
Nomifensine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04827
Urethane may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04829
Lysergic acid diethylamide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04832
Zimelidine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04833
Methaqualone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04834
Rapacuronium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04836
Amineptine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04841
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04842
Fluspirilene may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04871
Lorcaserin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04872
Osanetant may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04884
Dapoxetine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04885
Cilansetron may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04888
Bifeprunox may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04896
Milnacipran may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04903
Pagoclone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04908
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04917
Renzapride may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04946
Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04948
Lofexidine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB04953
Ezogabine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB05227
APD791 may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB05232
Tetrodotoxin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB05246
Methsuximide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB05271
Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB05316
Pimavanserin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB05541
Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB05542
Naronapride may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB05562
Naluzotan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB05607
PRX-08066 may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB05687
BL-1020 may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB05710
Gantacurium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06016
Cariprazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06077
Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06109
YKP-1358 may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06144
Sertindole may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06153
Pizotifen may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06201
Rufinamide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06216
Asenapine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06218
Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06264
Tolperisone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06282
Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06283
Ziconotide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06288
Amisulpride may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06446
Dotarizine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06458
Remacemide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06470
Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06512
Deramciclane may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06527
Tramiprosate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06529
Ocinaplon may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06554
Gaboxadol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06579
Adipiplon may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06582
Dextofisopam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06594
Agomelatine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06654
Safinamide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06660
Saredutant may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06678
Esmirtazapine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06684
Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06690
Nitrous oxide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06691
Mepyramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06700
Desvenlafaxine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06701
Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06716
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06731
Seproxetine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06753
Triclofos may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06770
Benzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB06797
Mebutamate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08059
Wortmannin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08329
Sulthiame may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08550
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08810
Cinitapride may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08811
Tofisopam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08815
Lurasidone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08839
Serotonin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08872
Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08883
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08892
Arbaclofen Placarbil may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08910
Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08918
Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08922
Perospirone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08927
Amperozide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08953
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08954
Ifenprodil may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08960
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08986
Etifoxine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08992
Eperisone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB08996
Dimetacrine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09000
Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09001
Barbexaclone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09011
Beclamide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09014
Captodiame may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09016
Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09017
Brotizolam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09021
Benzoctamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09023
Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09034
Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09068
Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09071
Tasimelteon may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09072
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09117
Paraldehyde may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09118
Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09119
Eslicarbazepine acetate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09128
Brexpiprazole may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09166
Etizolam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09167
Dosulepin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09184
Edivoxetine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09185
Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09186
Nisoxetine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09187
Lortalamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09190
Talopram may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09194
Etoperidone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09223
Blonanserin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09224
Melperone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09225
Zotepine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09226
Brilaroxazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09241
Methylene blue may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09243
Hydracarbazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09244
Pirlindole may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09245
Toloxatone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09246
Benmoxin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09247
Iproclozide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09248
Mebanazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09249
Octamoxin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09250
Pheniprazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09251
Phenoxypropazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09252
Pivhydrazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09253
Safrazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09254
Caroxazone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09286
Pipamperone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09289
Tianeptine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09307
Oxaprotiline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11156
Pyrantel may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11371
Alfaxalone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11376
Azaperone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11400
Doramectin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11428
Medetomidine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11477
Xylazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11540
Propiopromazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11543
Romifidine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11549
Tiletamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11552
Tricaine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11555
Zolazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11556
Detomidine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11582
Thiocolchicoside may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11664
Psilocybin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11675
Mosapride may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11686
Iferanserin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11699
Tropisetron may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11732
Lasmiditan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11755
Tetrahydrocannabivarin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11823
Esketamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11859
Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11868
Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11889
Lanicemine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB11957
Idalopirdine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12071
Vabicaserin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12093
Tetrahydropalmatine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12105
Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12110
m-Chlorophenylpiperazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12111
MK-212 may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12131
Vinpocetine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12163
Sarpogrelate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12177
Eplivanserin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12184
Gepirone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12229
Cerlapirdine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12273
Ecopipam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12308
Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12327
Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12338
Carisbamate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12361
Piclozotan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12395
Esreboxetine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12401
Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12427
Orvepitant may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12465
Ketanserin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12518
Raclopride may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12537
Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12576
AZD-3043 may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12590
Indiplon may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12661
Urapidil may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12693
Ritanserin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12710
Perazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12725
TD-8954 may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12833
Tandospirone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12867
Benperidol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12883
Eltoprazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12930
Opipramol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12951
Pivagabine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12958
Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12989
Neosaxitoxin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13014
Hypericin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13025
Tiapride may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13082
Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13099
Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13114
Amitriptylinoxide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13213
Butaperazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13219
Medifoxamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13221
Apronalide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13225
Dibenzepin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13233
Alaproclate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13234
Propanidid may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13246
Quinupramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13253
Proxibarbal may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13256
Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13273
Sultopride may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13295
Atracurium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13303
Febarbamate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13323
Trichloroethylene may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13324
Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13331
Pyrithyldione may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13335
Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13352
Deanol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13354
Phenprobamate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13357
Styramate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13362
Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13370
Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13377
Vinbarbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13382
Chlorproethazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13384
Melitracen may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13396
Neocitrullamon may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13402
Acetylglycinamide chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13403
Oxypertine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13411
Lofepramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13414
Fenyramidol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13420
Thiazinam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13437
Medazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13455
Phenibut may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13457
Oxaflozane may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13496
Iprindole may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13505
Emepronium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13520
Metergoline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13522
Mebicar may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13523
Veralipride may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13534
Gedocarnil may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13541
Iprazochrome may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13550
Bifemelane may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13552
Trifluperidol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13554
Moperone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13557
Thiopropazate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13572
Emylcamate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13577
Allobarbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13584
Gallamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13588
Naftidrofuryl may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13598
Diethyl ether may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13601
Oxiracetam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13623
Fabomotizole may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13642
Pridinol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13643
Loprazolam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13648
Alcuronium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13662
Hexapropymate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13665
Fluanisone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13676
Mosapramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13687
Niaprazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13690
Vinyl ether may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13733
Methylpentynol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13737
Cyclobarbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13745
Fazadinium bromide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13754
Mephenoxalone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13770
Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13782
Imipramine oxide may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13784
Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13791
Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13799
Ethadione may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13805
Reposal may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13817
Carbromal may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13837
Doxefazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13841
Clopenthixol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13872
Lormetazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13875
Harmaline may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13876
Brofaromine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13940
2,5-Dimethoxy-4-ethylthioamphetamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13948
N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13984
Cyclopropane may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB13993
MRK-409 may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB14010
5-methoxy-N,N-dimethyltryptamine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB14028
Nordazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB14050
Cannabidivarin may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB14185
Aripiprazole lauroxil may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB14509
Lithium carbonate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB14575
Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB14651
Perphenazine enanthate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB14672
Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB14715
Cinazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB14718
Pyrazolam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB14719
Bentazepam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB15203
JNJ-26489112 may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00967
Oxyphenonium may increase the central nervous system depressant (CNS depressant) activities of Desloratadine.
DB00653
Oxyphenonium may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.
DB11951
Lemborexant may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB12404
Remimazolam may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00751
Epinastine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB09532
The therapeutic efficacy of Secretin human can be decreased when used in combination with Oxyphenonium.
DB01235
The absorption of Levodopa can be decreased when combined with Oxyphenonium.
DB00455
Oxyphenonium may increase the anticholinergic activities of Loratadine.
DB00184
The risk or severity of Tachycardia can be increased when Nicotine is combined with Oxyphenonium.
DB00191
The risk or severity of Tachycardia can be increased when Phentermine is combined with Oxyphenonium.
DB00211
The risk or severity of Tachycardia can be increased when Midodrine is combined with Oxyphenonium.
DB00217
The risk or severity of Tachycardia can be increased when Bethanidine is combined with Oxyphenonium.
DB00221
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Isoetharine.
DB00261
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Anagrelide.
DB00368
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Norepinephrine.
DB00388
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Phenylephrine.
DB00397
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Phenylpropanolamine.
DB00598
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Labetalol.
DB00610
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Metaraminol.
DB00629
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Guanabenz.
DB00640
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Adenosine.
DB00668
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Epinephrine.
DB00723
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Methoxamine.
DB00810
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Biperiden.
DB00816
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Orciprenaline.
DB00830
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Phenmetrazine.
DB00841
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Dobutamine.
DB00852
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Pseudoephedrine.
DB00867
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Ritodrine.
DB00901
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Bitolterol.
DB00935
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Oxymetazoline.
DB00938
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Salmeterol.
DB00983
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Formoterol.
DB00988
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Dopamine.
DB01001
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Salbutamol.
DB01064
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Isoprenaline.
DB01102
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Arbutamine.
DB01166
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Cilostazol.
DB01255
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Lisdexamfetamine.
DB01274
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Arformoterol.
DB01291
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Pirbuterol.
DB01363
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Ephedra sinica root.
DB01364
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Ephedrine.
DB01365
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Mephentermine.
DB01366
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Procaterol.
DB01407
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Clenbuterol.
DB01467
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with 2,5-Dimethoxy-4-ethylamphetamine.
DB01556
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Chlorphentermine.
DB01576
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Dextroamphetamine.
DB01579
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Phendimetrazine.
DB05039
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Indacaterol.
DB05395
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Amibegron.
DB06152
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Nylidrin.
DB06190
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Solabegron.
DB06262
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Droxidopa.
DB06694
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Xylometazoline.
DB06706
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Isometheptene.
DB06707
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Levonordefrin.
DB06711
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Naphazoline.
DB06764
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Tetryzoline.
DB06814
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Protokylol.
DB08841
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Tyramine.
DB08925
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Adrafinil.
DB08941
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Isoxsuprine.
DB08957
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Hexoprenaline.
DB08985
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Etilefrine.
DB09080
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Olodaterol.
DB09082
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Vilanterol.
DB09202
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Cirazoline.
DB09203
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Synephrine.
DB09242
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Moxonidine.
DB09273
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Doxofylline.
DB09480
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Iofetamine I-123.
DB11124
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Racepinephrine.
DB11278
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with DL-Methylephedrine.
DB11373
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Amitraz.
DB11541
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Ractopamine.
DB11587
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Etafedrine.
DB11738
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Rilmenidine.
DB11785
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Anisodamine.
DB11871
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with PF-00610355.
DB12080
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Ritobegron.
DB12100
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Abediterol.
DB12248
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Tulobuterol.
DB12313
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Dopexamine.
DB12779
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Higenamine.
DB12846
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Reproterol.
DB13064
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Tramazoline.
DB13108
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Mephedrone.
DB13139
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Levosalbutamol.
DB13251
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Octopamine.
DB13341
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Fenozolone.
DB13378
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Norfenefrine.
DB13398
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Oxyfedrine.
DB13559
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Rimiterol.
DB13624
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Methoxyphenamine.
DB13692
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Tretoquinol.
DB13703
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Gepefrine.
DB13777
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Prenalterol.
DB13781
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Xamoterol.
DB13852
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Mefenorex.
DB14009
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Medical Cannabis.
DB01184
The therapeutic efficacy of Domperidone can be decreased when used in combination with Oxyphenonium.
DB13074
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Oxyphenonium.
DB14754
The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Oxyphenonium.
DB00843
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Donepezil.
DB01233
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Metoclopramide.
DB14881
The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Oxyphenonium is combined with Oliceridine.

序列

实验性质

Melting Point
191.5 °C
PhysProp
logP
0.17

外部标识符

resource：ChEBI
identifier：94329
resource：PubChem Compound
identifier：5749
resource：PubChem Substance
identifier：46508840
resource：ChemSpider
identifier：5547
resource：PharmGKB
identifier：PA164752252
resource：Therapeutic Targets Database
identifier：DAP001124
resource：Wikipedia
identifier：Oxyphenonium_bromide
resource：ChEMBL
identifier：CHEMBL1201286
resource：RxCUI
identifier：7818

外部链接

路径

目标

id:BE0000092
name:Muscarinic acetylcholine receptor M1
organism:Humans
action:antagonist
Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
Eglen RM, Whiting RL: Competitive and non-competitive antagonism exhibited by 'selective' antagonists at atrial and ileal muscarinic receptor subtypes. Br J Pharmacol. 1987 Apr;90(4):701-7.
Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
known-action:yes
name:Muscarinic acetylcholine receptor M1
general-function:Phosphatidylinositol phospholipase c activity
specific-function:The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover.
gene-name:CHRM1
locus:11q13
cellular-location:Cell membrane
transmembrane-regions:25-47 62-82 100-121 142-164 187-209 367-387 402-421
signal-regions:
theoretical-pi:9.67
molecular-weight:51420.375
chromosome-location:11
organism:Humans
external-identifiers:HUGO Gene Nomenclature Committee (HGNC)HGNC:1950GenAtlasCHRM1GenBank Gene DatabaseX52068GenBank Protein Database34451IUPHAR13Guide to Pharmacology13UniProtKBP11229UniProt AccessionACM1_HUMAN
synonyms:
amino-acid-sequence:>lcl|BSEQ0000184|Muscarinic acetylcholine receptor M1 MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISFKVNTELKTVN NYFLLSLACADLIIGTFSMNLYTTYLLMGHWALGTLACDLWLALDYVASNASVMNLLLIS FDRYFSVTRPLSYRAKRTPRRAALMIGLAWLVSFVLWAPAILFWQYLVGERTVLAGQCYI QFLSQPIITFGTAMAAFYLPVTVMCTLYWRIYRETENRARELAALQGSETPGKGGGSSSS SERSQPGAEGSPETPPGRCCRCCRAPRLLQAYSWKEEEEEDEGSMESLTSSEGEEPGSEV VIKMPMVDPEAQAPTKQPPRSSPNTVKRPTKKGRDRAGKGQKPRGKEQLAKRKTFSLVKE KKAARTLSAILLAFILTWTPYNIMVLVSTFCKDCVPETLWELGYWLCYVNSTINPMCYAL CNKAFRDTFRLLLLCRWDKRRWRKIPKRPGSVHRTPSRQC
gene-sequence:>lcl|BSEQ0009929|Muscarinic acetylcholine receptor M1 (CHRM1) ATGAACACTTCAGCCCCACCTGCTGTCAGCCCCAACATCACCGTCCTGGCACCAGGAAAG GGTCCCTGGCAAGTGGCCTTCATTGGGATCACCACGGGCCTCCTGTCGCTAGCCACAGTG ACAGGCAACCTGCTGGTACTCATCTCTTTCAAGGTCAACACGGAGCTCAAGACAGTCAAT AACTACTTCCTGCTGAGCCTGGCCTGTGCTGACCTCATCATCGGTACCTTCTCCATGAAC CTCTATACCACGTACCTGCTCATGGGCCACTGGGCTCTGGGCACGCTGGCTTGTGACCTC TGGCTGGCCCTGGACTATGTGGCCAGCAATGCCTCCGTCATGAATCTGCTGCTCATCAGC TTTGACCGCTACTTCTCCGTGACTCGGCCCCTGAGCTACCGTGCCAAGCGCACACCCCGC CGGGCAGCTCTGATGATCGGCCTGGCCTGGCTGGTTTCCTTTGTGCTCTGGGCCCCAGCC ATCCTCTTCTGGCAGTACCTGGTAGGGGAGCGGACAGTGCTAGCTGGGCAGTGCTACATC CAGTTCCTCTCCCAGCCCATCATCACCTTTGGCACAGCCATGGCTGCCTTCTACCTCCCT GTCACAGTCATGTGCACGCTCTACTGGCGCATCTACCGGGAGACAGAGAACCGAGCACGG GAGCTGGCAGCCCTTCAGGGCTCCGAGACGCCAGGCAAAGGGGGTGGCAGCAGCAGCAGC TCAGAGAGGTCTCAGCCAGGGGCTGAGGGCTCACCAGAGACTCCTCCAGGCCGCTGCTGT CGCTGCTGCCGGGCCCCCAGGCTGCTGCAGGCCTACAGCTGGAAGGAAGAAGAGGAAGAG GACGAAGGCTCCATGGAGTCCCTCACATCCTCAGAGGGAGAGGAGCCTGGCTCCGAAGTG GTGATCAAGATGCCAATGGTGGACCCCGAGGCACAGGCCCCCACCAAGCAGCCCCCACGG AGCTCCCCAAATACAGTCAAGAGGCCGACTAAGAAAGGGCGTGATCGAGCTGGCAAGGGC CAGAAGCCCCGTGGAAAGGAGCAGCTGGCCAAGCGGAAGACCTTCTCGCTGGTCAAGGAG AAGAAGGCGGCTCGGACCCTGAGTGCCATCCTCCTGGCCTTCATCCTCACCTGGACACCG TACAACATCATGGTGCTGGTGTCCACCTTCTGCAAGGACTGTGTTCCCGAGACCCTGTGG GAGCTGGGCTACTGGCTGTGCTACGTCAACAGCACCATCAACCCCATGTGCTACGCACTC TGCAACAAAGCCTTCCGGGACACCTTTCGCCTGCTGCTGCTTTGCCGCTGGGACAAGAGA CGCTGGCGCAAGATCCCCAAGCGCCCTGGCTCCGTGCACCGCACTCCCTCCCGCCAATGC TGA
pfams:PF000017tm_1
go-classifiers:componentasymmetric synapsecomponentaxon terminuscomponentcell junctioncomponentdendritecomponentintegral component of plasma membranecomponentmembranecomponentplasma membranecomponentpostsynaptic densitycomponentpostsynaptic membranecomponentsynapsefunctiondrug bindingfunctionG-protein coupled acetylcholine receptor activityfunctionphosphatidylinositol phospholipase C activityprocessadenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathwayprocesscell proliferationprocesscellular protein modification processprocesscognitionprocessentrainment of circadian clockprocessG-protein coupled acetylcholine receptor signaling pathwayprocessG-protein coupled receptor signaling pathwayprocessnervous system developmentprocessneuromuscular synaptic transmissionprocessphospholipase C-activating G-protein coupled acetylcholine receptor signaling pathwayprocessphototransduction, visible lightprocesspositive regulation of cell proliferationprocesspositive regulation of intracellular protein transportprocesspositive regulation of ion transportprocessprotein kinase C-activating G-protein coupled receptor signaling pathwayprocessregulation of locomotionprocesssaliva secretionprocesssensory perception of chemical stimulusprocesssignal transductionprocesssynaptic transmission, cholinergic

酶

载体

运输工具

药物反应

效应

不良反应